PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004 - 2005 GRAND ROUNDS SCHEDULE
Select and click in the month's schedule you wish to view.
Previous academic year schedules: 2001-2002    2002-2003   2003-2004

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of one category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity."

 September 2004

 No Grand Rounds Scheduled

9/21/04
11:00am

No Grand Rounds Scheduled

No Grand Rounds Scheduled

Questions or  comments concerning these activities?  Write, Call, FAX, or E-mail: 
Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

October 2004

Ten years after the discovery of the genetic causing disease, we will review the psychiatric and neurological conditions associated with Huntington’s disease and describe the recent progress in basic research and more specifically present our recent findings on the mitochondrial dysfunction caused by the huntingt" protein mutation.

Objectives:   
Participants will gain familiarity with 1) the psychiatric and neurological features of Huntington’s disease 2) the resent findings that contribute to elucidate the molecular mechanisms that underlie neurodegeneration.  

10/19/04
11:00am

Depression and its Treatment;  Relationship to Cardiovascular Risk
Lelland C. Tolbert, Ph.D., Associate Professor
Department of Psychiatry & Behavioral Neurobiology
Division of Child and Adolescent Psychiatry
University of Alabama School of Medicine

The relationship between depression and adverse cardiovascular events will be discussed.  A research project identifying abnormalities in thrombus formation in individuals with depression and changes in these with treatments will be summarized.

Objectives:   
Participants will recognize another reason to aggressively treat depression and obtain information relevant to treatment choices.

References:  
1. Markovitz JH, Tolbert LC, Winders SE. Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers. Atherioscier. Thromb. Vase Biol. 1999; 19:762-766.

2. Markovitz JH. Shuster JL, Chitwood WS, Tolbert LC. Platelet activation in depression and effects of sertraline treatment: An open-label study. Am. J. Psychiatry 2000; 157:1006-1008.

3. Serebruzny VL, Glessrnan AH, Malinin AT, et. al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. (SADHEART study). Circulation, 2003; 108:939.

Objectives:   
To present the complex interactions between therapist and consumer in the treatment of mental illness.

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

November 2004

Atypical Antipsychotics and the Metabolic Syndrome
Richard Scott Rosenthal, M.D., Assistant Professor
Division of Endocrinology, Diabetes & Metabolism
University of Alabama School of Medicine

Presentation Description and Objectives:  
1)  Recognize the signs and symptoms of the metabolic syndrome in people with schizophrenia and bipolar disorders, whether or not related to its treatments  
2) Describe the interrelationships between conditions and treatments of schizophrenia, bipolar disorders, and the metabolic syndrome  
3)  Initiate preventive and/or therapeutic interventions, or seek consultative assistance to do so, when manifestation of diabetes or other components of the insulin resistance syndrome or metabolic syndrome are present  
4)  Examine the epidemiology of weight gain, diabetes, and cardiovascular disease in patients with schizophrenia  
5)  Discuss the current data and controversies regarding the relationship between new-onset diabetes, weight gain and lipid abnormalities, and atypical antipsychotics  
6)  Explain the importance of developing a treatment strategy to minimize the atypical antipsychotic induced metabolic impact in patients who are at risk.

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

December 2004 

Objectives: 1)  Participants will learn about current treatment strategies of mood disorders, including bipolar disorder and major depressive disorder.  2)  Participants will learn about first-hand clinical research data and current clinical trials relevant to the efficacy of atypical antipsychotics in the treatment of mood disorders.  3)  Participants will learn about the molecular mechanisms of action of atypical antipsychotics in the regulation of neurotransmission and its implication in the treatment of mood disorders.

References:  
1.  Li, X., May, R.S., Tolbert, L.C., Jackson, W.T., Flournoy, J. Baxter, Jr. L.R., Risperidone vs Haloperidol Augmentation in Selective Serotonin Reuptake Inhibitor-Refractory  Obsessive-Compulsive Disorder. Submitted to J. Clin. Psychiatry, 2004.
 
2.  Li, X. Wawa Zhu, Myoung-Sun Roh, Ari B. Friedman, Kelley Rosborough, and Richard S. Jope. Regulation of GSK3 in vivo by serotonergic activity in mouse brain. Neuropsychopharmacology, 29:1426-1431, 2004.

3.   Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology, 28(2):402-12, 2003.

4.   Sarno, P.D., Li, X. Jope, R.S. Regulation of Akt and glycogen synthase kinase-3b phosphorylation by sodium valproate and lithium. Neuropharmacology, 43:1158-1164, 2002

Liver Disease:  Transplant Neuropsychology
Brendan M. McGuire, M.D.,  Associate Professor
Department of Medicine, Division of Gastroenterology/Hepatology
University of Alabama School of Medicine
Beverly Bush, Ph.D.,  Associate Professor
Department of Psychiatry & Behavioral Neurobiology, Division of Geriatric Psychiatry
University of Alabama School of Medicine

This presentation will provide the audience with a brief description of liver disease and how liver disease affects the brain, mental status, and cognitive functioning.  Attendees will also be presented with information about the neuropsychiatric complications of advanced liver disease and the treatment of these complications.

Objectives:   At the end of the presentation, attendees will have a knowledge or understanding of:
1)  the patient population undergoing transplantation for end stage liver disease (ESLD); 2) how ESLD results in neuropsychiatric symptoms including altered mental status and cognitive functioning; 3) psychiatric difficulties in this population and treatment options. 4)  Current research will be reviewed.

References:  Will be provided

NO GRAND ROUNDS SCHEDULED.
HAPPY HOLIDAYS!

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

January 2005

The Psychiatrist's Role in Corporate Workplace Violence
Rahn Kennedy Bailey, MD, FAPA
Bryce Hospital, Tuscaloosa, Alabama

Objectives:  TBA

References: Scarno VR, Bailey, RK.  The Psychiatrist's Role in Corporate Workplace Violence.  Am J Forensic Psych April, 2004

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

 February 2005

2/15/05
11:00am

We gratefully acknowledge an educational grant  from GlaxoSmithKline to support Dr. Davidson's visit.

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

March 2005

 ANNUAL C.J. ROSECRANS MEMORIAL LECTURE
Rorschach Inkblot Test: Scientifically Based Personality Assessment Instrument or...Projection of a Psychologist's Fantasies?
Anthony D. Sciara, Ph.D., ABPP, CLCP
Private Practice, Asheville, North Carolina
Diplomat in Clinical Psychology, American Board of Professional Psychology, 1982

This presentation will review the history and development of the Rorschach along with some commonly held misinformation regarding the test.  Scientific data will be presented along with a general description of the use of the Rorschach in various clinical settings.

Objectives:  This  presentation will 
1) Give history and development of Rorschach 
2) Present the foundations 
3) Dispel myths 
4)  Present research basis 
5)  Present usefulness/limitations

Objectives:  
(1)  To discuss certain common misconceptions about psychodynamic psychotherapy.  (2)  To provide a brief overview of the models of the mind as they are employed in psychodynamic psychotherapy.  (3)  To present an understanding of the psychotherapeutic process as it is informed by contemporary psychoanalysis.  (4)  To introduce recent advances in the understanding of the mechanisms of change that make psychodynamic psychotherapy an effective treatment for many conditions.

References:   TBA

3/15/05
11:00am

Objectives:  
1)  To understand the degree of co-morbidity of nicotine abuse/dependence in the mentally ill.
2)  To discuss from a biological perspective the possible causes of increased risk of nicotine abuse/dependence in people with schizophrenia.
3)  To understand the implications of nicotine abuse/dependence to psychiatric diagnosis and treatment.

References:   
Will be provided at the presentation.

Objectives:  
To demonstrate how psychiatrist are more adequately equipped in their training to manage the complexities of pain management.

References:   
Will be provided at the presentation.

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

 April 2005

Acceptance and Commitment Therapy:  A Transdiagnostic Approach to Problems in Living
Kelly G. Wilson, Ph.D.
Assistant Professor, Department of Psychology 
University of Mississippi 
 
ACT is one of the third wave of emerging behavioral treatments.  ACT is based upon the core behavioral principles that drive our most well established treatments.  However in contrast to some earlier behavioral treatments, the ACT approach integrates acceptance, mindfulness, and values-centered interventions along with direct behavior change and commitment interventions.  Both process and outcome data will be presented relevant to traditional diagnostic categories, including psychosis and substance abuse, and in domains outside traditional diagnostic categories, such as pain, stress, and burnout.
  
Objectives:  The presentation will provide 1) an Acceptance and Commitment Therapy (ACT) conceptualization of psychological problems, 2) putative change processes, 3) ACT intervention components, and 4) data on both therapeutic outcome and process.

4/19/05
11:00am

Objectives:  To gain better understanding of the training programs and their organization.
.
.

Patients with Personality Disorders are common in psychiatric pracitce.  Making an accurate diagnosis and documenting it appropriately may be problematic.  During the presentation we will discuss current understanding of Personality Disorders.

Objectives:  Better understanding of Personality Disorders including  1)  Definition  2)  Classification    3)  Diagnostic Criteria  4)  Psychodynamic Factors  5)  Therapeutic Approaches

References:   Will be provided at the presentation

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME

CLINICAL SERVICES

• Center for Psychiatric Medicine
  
• Adult Psychiatry
  
• Child/Adolescent Psychiatry
  
• Geriatric Psychiatry
  
• Addiction Recovery Program 
  
• Community Psychiatry

  The Department of Psychiatry

and 

Behavioral Neurobiology

2004/2005 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

 May 2005

Mindfulness Practice as a Psychotherapy Intervention 
Clive J. Robins, Ph.D., ABPP
Associate Clinical Professor, Departments of Psychology and Psychiatry
Director of the Behavior Research and Therapy Program
Duke University Medical Center

The concept of mindfulness will be introduced and the role of mindfulness practice in DBT will be described.  Data on the effects of mindfulness on psychological functioning will be summarized.  The presentation will include brief experiential exercises in mindfulness practice.

Objectives:  1) Understand the concept of mindfulness  2)  Describe hw mindfulness practice is taught in dialectical behavior therapy  3)  Summarize the research data on effects of mindfulness practice on mental health outcomes

References:  Will be provided at the presentation

The Use of a Short Story to Resolve a Clinical Impasse in Psychotherapy:  What Psychodynamic Psychotherapists Can Learn from Creative Writers about the Therapeutic Space and the Process of Containment
Fred L. Griffin, M.D.
Associate Professor
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

When working in psychodynamic psychotherapy with very ill patients, the emotional force-field between patient and therapist may become so intense that the therapist may lose the capacity to think clearly.  He or she may be robbed of the capacity to accurately assess the nature of the clinical situation and, thereby, may be unable to make appropriate interventions.  In this presentation, Dr. Griffin will describe how a short story assisted him in resolving a therapeutic impasse with such a patient.  He will then discuss his understanding of the mechanism whereby this work of fiction served as a “consultant” to him. 

Objectives:  1)  Demonstrate the use of a short story to facilitate the therapist’s capacity to restore a collapsed analytic space in a case of therapeutic impasse   2)  Discuss a psychotherapeutic approach with a (bipolar) patient’s resistance to take medication  3)Present a model whereby both therapists (in the psychotherapeutic situation) and creative writers (in the act of writing) “process” emotional experience     4)  Introduce Bion’s concepts of projective identification and containment   5)   Describe approaches of the poet/imaginative writer/physician William Carlos Williams to creating language for clinical experience

References:  
Bion, W. (1959).  Attacks on Linking.  Int. J. Psychoanal., 40:308-315.
------- (1962).  The Psycho-analytic Theory of Thinking.  Int. J. Psychoanal., 43:306-310.
Griffin , F. (2005).  Clinical Conversations between Psychoanalysis and Imaginative Literature,
     Psychoanalytic Quarterly, April 2005.
Williams, W.C. (1932).  The Use of Force. In William Carlos Williams: The Doctor Stories, ed. R. Coles.        New York : New Directions Books, 1984.

5/17/05
11:00am

Maternal Depression
Naila Siddiqui, M.D.
Child/Adolescent Psychiatry Sub-Specialist 
The challenges surrounding depression during pregnancy and postpartum period will be presented.

Objectives:  To present a common clinical scenario and the impact of illness on mother and baby

References:  N/A

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu